Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Merck Sharp & Dohme Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (146)
Australian public assessment report (AusPar) (4)

Date

2018 (1)
2017 (13)
2016 (38)
2015 (87)
2014 (11)

Search

Sponsor content

150 result(s) found, displaying 91 to 100

H-B-VAX II HEPATITIS B VACCINE RECOMBINANT hepatitis B-surface antigen recombinant 5mcg 0.5mL injection vial B-HEPAVAX II 5ug inj 0.5mL vial Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
CLINORIL sulindac 200mg tablet US/Australian sourced cardboard carton export Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PedvaxHIB haemophilus b conjugate meningococcal protein conjugate vaccine powder for injection vial with diluent vial Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PROSCAR 5 mg tablet blister pack Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEPCID AC famotidine 10mg tablet UK sourced blister pack Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
HB-VAX II Hepatitis B Vaccine recombinant 2.5 microgram/0.5mL injection vial Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
VAQTA Hepatitis A Vaccine Inactivated 25 units/0.5mL injection vial (export) Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
VAQTA Hepatitis A Vaccine Inactivated 50 units/1mL injection vial (export) Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
LIQUID PEDVAX HIB HAEMOPHILUS TYPE B CONJUGATE VACCINE (Meningococcal Protein Conjugate) injection vial Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PROPECIA finasteride 1mg tablet blister pack Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd

Pages

First page
Previous page
…
Page 6
Page 7
Page 8
Page 9
Current page 10
Page 11
Page 12
Page 13
Page 14
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.